18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia

Haematologica

Volumn 96, Issue 10, 2011, Pages 1552-1556

  Stölzel, Friedrich ^a   Röllig, Christoph ^a   Radke, Jörgen ^a   Mohr, Brigitte ^a   Platzbecker, Uwe ^a   Bornhäuser, Martin ^a   Paulus, Tobias ^a   Ehninger, Gerhard ^a   Zoephel, Klaus ^a   Schaich, Markus ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

18F FDG PET CT; Acute myeloid leukemia (AML); Extramedullary AML; Myeloid sarcoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; GRANULOCYTIC SARCOMA; HUMAN; HUMAN TISSUE; LEUKEMIA RELAPSE; MALE; REFRACTORY PERIOD; MIDDLE AGED; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SARCOMA, MYELOID; SENSITIVITY AND SPECIFICITY;

EID: 80053620912     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.045047     Document Type: Article

References (24)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2008:140-1.
2. Chong G, Byrnes G, Szer J, Grigg A. Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant. 2000;26(9):1011-5.
3. Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O'Brien S, Brandt M, et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer. 2008;113(6):1370-8.
4. Bekassy AN, Hermans J, Gorin NC, Gratwohl A. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1996;17(5):801-8.
5. Mortimer J, Blinder MA, Schulman S, Appelbaum FR, Buckner CD, Clift RA, et al. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol. 1989;7(1):50-7.
6. Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340-50.
7. Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weissinger E, Bunjes D, et al. Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood. 2006;108(3):1092-9.
8. Schaich M, Schlenk RF, Al-Ali HK, Dohner H, Ganser A, Heil G, et al. Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Haematologica. 2007;92(6):763-70.
9. Hutchings M, Specht L. PET/CT in the management of haematological malignancies. Eur J Haematol. 2008;80(5):369-80.
10. Karlin L, Itti E, Pautas C, Rachid M, Bories D, Cordonnier C, et al. PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma. Haematologica. 2006;91(12 Suppl):ECR54.
11. Kuenzle K, Taverna C, Steinert HC. Detection of extramedullary infiltrates in acute myelogenous leukemia with wholebody positron emission tomography and 2- deoxy-2-[18F]-fluoro-D-glucose. Mol Imaging Biol. 2002;4(2):179-83.
12. Mantzarides M, Bonardel G, Fagot T, Gontier E, Soret M, Revel TD, et al. Granulocytic sarcomas evaluated with F-18- fluorodeoxyglucose PET. Clin Nucl Med. 2008;33(2):115-7.
13. von Falck C, Laenger F, Knapp WH, Galanski M. F-18 FDG PET/CT showing bilateral breast involvement in acute myeloid leukemia relapse. Clin Nucl Med. 2009;34(10):713-5.
14. Ueda K, Ichikawa M, Takahashi M, Momose T, Ohtomo K, Kurokawa M. FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy. Leuk Res. 2010;34(9): 1239-41.
15. Aschoff P, Hantschel M, Oksuz M, Werner MK, Lichy M, Vogel W, et al. Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma. Initial results. Nuklearmedizin. 2009; 48(5):185-91.
16. Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M, et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood. 2006;107(10):4011-20.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130 (6):461-70.
18. Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37(1):181-200.
19. Juweid ME. FDG-PET/CT in Lymphoma. Methods Mol Biol. 2011;727:1-19.
20. Buck AK, Bommer M, Juweid ME, Glatting G, Stilgenbauer S, Mottaghy FM, et al. First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine. J Nucl Med. 2008;49 (11):1756-62.
21. Dohner K, Schlenk RF, Habdank M, Scholl C, Rucker FG, Corbacioglu A, et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood. 2005;106(12):3740-6.
22. Falini B, Lenze D, Hasserjian R, Coupland S, Jaehne D, Soupir C, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia. 2007;21(7): 1566-70.
23. Cunningham I. Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma. 2006;47(9):1754-67.
24. Masri A, Goldman DC, Asbaghi SA, Clark HA, Leon RP, Liu Q, Hickey RD, Grompe M, Kurre P and Fleming WH. Acute Myeloid Leukemia Cells Fuse with Vascular Endothelium. Blood (ASH Annual Meeting Abstracts). 2010;112:1490.